STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

LeMaitre Will Announce Third Quarter 2024 Earnings Results October 31, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

LeMaitre Vascular (Nasdaq:LMAT) has announced that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

Interested parties can access the live call by registering online, after which they will receive dial-in information and a PIN. An audio webcast will also be available live and for replay at www.lemaitre.com/investor.

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition affecting over 200 million people worldwide. The company focuses on developing, manufacturing, and marketing disposable and implantable vascular devices for vascular surgeons.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

BURLINGTON, Mass., Oct. 15, 2024 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.

Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.

About LeMaitre

LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.


FAQ

When will LeMaitre Vascular (LMAT) release its Q3 2024 earnings?

LeMaitre Vascular (LMAT) will release its third quarter 2024 financial results on Thursday, October 31, 2024, after the market close.

What time is LeMaitre Vascular's (LMAT) Q3 2024 earnings call scheduled?

LeMaitre Vascular's (LMAT) Q3 2024 earnings conference call is scheduled for 5:00 PM ET on Thursday, October 31, 2024.

How can investors access LeMaitre Vascular's (LMAT) Q3 2024 earnings call?

Investors can access LeMaitre Vascular's (LMAT) Q3 2024 earnings call by registering online to receive dial-in information and a PIN. An audio webcast will also be available at www.lemaitre.com/investor.

What is LeMaitre Vascular's (LMAT) main business focus?

LeMaitre Vascular (LMAT) focuses on providing devices, implants, and services for the treatment of peripheral vascular disease, primarily serving vascular surgeons.
Lemaitre Vasculr

NASDAQ:LMAT

LMAT Rankings

LMAT Latest News

LMAT Latest SEC Filings

LMAT Stock Data

1.90B
20.90M
7.8%
95.11%
5.96%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
BURLINGTON